CD274 and neoplasm: Unsurprisingly, these studies consistently demonstrated tumor delivery of NPs, blockade of PD-1/PD-L1 signaling, and associated therapeutic benefits including tumor growth inhibition and prolonged survival times of NP-ICI-treated mice compared to controls.